These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7022712)

  • 1. The role of liver membrane antigens as targets in autoimmune type liver disease.
    Meyer zum Büschenfelde KH; Hütteroth TH; Manns M; Möller B
    Springer Semin Immunopathol; 1980 Dec; 3(3):297-315. PubMed ID: 7022712
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets.
    Meyer zum Büschenfelde KH; Hütteroth TH; Arnold W; Hopf U
    Prog Liver Dis; 1979; 6():407-24. PubMed ID: 396565
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver-specific protein in perspective.
    Chisari FV
    Gastroenterology; 1980 Jan; 78(1):168-70. PubMed ID: 6153072
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmunity in liver disease.
    McFarlane IG
    Clin Sci (Lond); 1984 Dec; 67(6):569-78. PubMed ID: 6386282
    [No Abstract]   [Full Text] [Related]  

  • 5. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of autoimmune liver disease.
    Meyer zum Büschenfelde KH; Manns M
    Semin Liver Dis; 1984 Feb; 4(1):26-35. PubMed ID: 6231727
    [No Abstract]   [Full Text] [Related]  

  • 7. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
    Eddleston AL; Williams R
    Lancet; 1974 Dec; 2(7896):1543-5. PubMed ID: 4140983
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.
    Uibo RM; Helin HJ; Krohn KJ
    Clin Exp Immunol; 1982 May; 48(2):505-12. PubMed ID: 7105494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in liver diseases.
    Doniach D
    Prog Clin Immunol; 1972; 1():45-70. PubMed ID: 4142094
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro.
    Poralla T; Ramadori G; Dienes HP; Manns M; Gerken G; Dippold W; Hütteroth TH; Meyer zum Büschenfelde KH
    J Hepatol; 1987 Jun; 4(3):373-80. PubMed ID: 3598165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Symposium on autoimmune diseases. Studies on mechanism of liver cell damage and significances of autoantibodies in autoimmune liver diseases].
    Nagashima H
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):598-9. PubMed ID: 4565167
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune processes.
    Ann Biol Clin (Paris); 1985; 43(4):443-9. PubMed ID: 4091307
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis.
    O'Brien CJ; Vento S; Donaldson PT; McSorley CG; McFarlane IG; Williams R; Eddleston AL
    Lancet; 1986 Feb; 1(8477):350-3. PubMed ID: 2868297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases.
    Smith MG; Eddleston AL; Williams R
    Clin Gastroenterol; 1975 May; 4(2):297-313. PubMed ID: 1092487
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.
    Manns M; Meyer zum Büschenfelde KH; Hess G
    Gut; 1980 Nov; 21(11):955-61. PubMed ID: 7450561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to liver-specific lipoprotein and liver membrane antigen: a tabular interpretative review.
    Frazer IH; Mackay IR
    J Clin Lab Immunol; 1984 Aug; 14(4):165-7. PubMed ID: 6492122
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopathogenesis of chronic hepatitis: a review.
    Mackay IR; Popper H
    Aust N Z J Med; 1973 Feb; 3(1):79-88. PubMed ID: 4573196
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease.
    Mieli-Vergani G; Psacharopoulos HT; Nicholson AM; Eddleston AL; Mowat AP; Williams R
    Arch Dis Child; 1980 Sep; 55(9):696-701. PubMed ID: 7436533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell inducers of suppressor lymphocytes control liver-directed autoreactivity.
    Vento S; O'Brien CJ; McFarlane IG; Williams R; Eddleston AL
    Lancet; 1987 Apr; 1(8538):886-8. PubMed ID: 2882291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.